Invitrogen™ Kit ELISA NSE humain

Réf. : BL-RE-093199Réf. fabricant : EEL040 96 Tests
694,00 € HT

Neuron specific enolase (NSE, ENO1, ENO2, ENO3) is an enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in the glycolytic pathway, and the reverse reaction in gluconeogenesis. NSE has a high stability in biological…

Numéro d’adhésion
P09104
Plage de dosage
2.34 to 150 ng/mL
Sensibilité du dosage
1.4 ng/mL
Conjugué
HRP
Type de produit
ELISA
Marque
Invitrogen

Neuron specific enolase (NSE, ENO1, ENO2, ENO3) is an enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in the glycolytic pathway, and the reverse reaction in gluconeogenesis. NSE has a high stability in biological…

Neuron specific enolase (NSE, ENO1, ENO2, ENO3) is an enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in the glycolytic pathway, and the reverse reaction in gluconeogenesis. NSE has a high stability in biological fluids and can easily diffuse to the extracellular medium and cerebrospinal fluid (CSF) when neuronal membranes are injured.NSE is one of three mammalian enolases, which are also known as ENO1, ENO2, and ENO3 or alternately as enolase alpha, beta and gamma. The alpha-subunit is expressed in most tissues, the beta-subunit only in muscle, and the gamma-subunit is expressed primarily in neurons, in normal and in neoplastic neuroendocrine cells. Co-expression of NSE and chromogranin A is common in neuroendocrine neoplasms. Since neurons require a great deal of energy, they are very rich in glycolytic enzymes such a GAPDH and NSE. Antibodies to NSE protein are useful to identify neuronal cell bodies, developing neuronal lineage and neuroendocrine cells. Release of NSE from damaged neurons into CSF and blood has also been used as a biomarker of neuronal injury. NSE is used clinically as a sensitive and useful marker of neuronal damage in several neurological disorders including stroke, hypoxic brain damage, status epilepticus, Creutzfeldt-Jakob disease, and herpetic encephalitis. Further, NSE is found in elevated concentrations in plasma and certain neoplasias that include pediatric neuroblastoma and small cell lung cancer.

Sensibilité

Sensibilité du dosage : 1,4 ng/mL.

Plage de mesure

Plage de dosage : 2,34 à 150 ng/mL.

Durée du dosage

Durée totale du dosage : 3 h 30 min.

Échantillons

Type d’échantillon : Plasma (volume 100 µL).

Conjugué

Conjugué : HRP.

Caractéristiques techniques

Général
MarqueInvitrogen
Réf. fournisseur (Fisher Scientific)18067454
Caractéristiques
Numéro d’adhésionP09104
Plage de dosage2.34 to 150 ng/mL
Sensibilité du dosage1.4 ng/mL
ConjuguéHRP
Type de produitELISA
Type d’échantillonPlasma
À utiliser avec (équipement)Colorimetric Microplate Reader
Identification génétique (Entrez)2026
Symbole de gène(s)ENO2
Coefficient de variation inter-dosage<10%
Coefficient de variation intra-dosage<10%
Contenus des kitsPre-coated 96 well plate, Standard, Biotinylated Detection Antibody, HRP Conjugate, Standard & Sample Diluent, Biotinylated Detection Antibody Diluent, HRP Conjugate Diluent, Wash Buffer, TMB Substrate, Stop Solution, Plate Sealer
Marqueur ou colorantHRP
Quantité96 Tests
État réglementaireRUO
CibleHuman
Heure du test1 hr 20 min
Caractéristiques physiques
Volume d’échantillon100 µL
Stockage et expédition
Conditions de stockageRefer to product documentation for component specific storage temperature.
Durée totale du dosage3 hr 30 min

Origine et douane

Réf. fabricantEEL040
Pays d’origineChine
Code douanier (SH)3822 11 00 00
Une question, une configuration particulière ?
Contactez-nous pour un devis.